Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide
Background NY-ESO-1 is a tumor-specific, highly immunogenic, human germ cell antigen of the MAGE-1 family that is a promising vaccine and cell therapy candidate in clinical trial development. The mouse genome does not encode an NY-ESO-1 homolog thereby not subjecting transgenic T-cells to thymic tol...
        Saved in:
      
    
          | Main Authors: | , , , , , , , , , | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | BMJ Publishing Group
    
        2021-06-01 | 
| Series: | Journal for ImmunoTherapy of Cancer | 
| Online Access: | https://jitc.bmj.com/content/9/6/e002544.full | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
 
       